Cargando…
A bioavailable cathepsin S nitrile inhibitor abrogates tumor development
BACKGROUND: Cathepsin S has been implicated in a variety of malignancies with genetic ablation studies demonstrating a key role in tumor invasion and neo-angiogenesis. Thus, the application of cathepsin S inhibitors may have clinical utility in the treatment of cancer. In this investigation, we appl...
Autores principales: | Wilkinson, Richard D. A., Young, Andrew, Burden, Roberta E., Williams, Rich, Scott, Christopher J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839156/ https://www.ncbi.nlm.nih.gov/pubmed/27097645 http://dx.doi.org/10.1186/s12943-016-0513-7 |
Ejemplares similares
-
CCL2 is transcriptionally controlled by the lysosomal protease cathepsin S in a CD74-dependent manner
por: Wilkinson, Richard D.A., et al.
Publicado: (2015) -
A Novel Role for Cathepsin S as a Potential Biomarker in Triple Negative Breast Cancer
por: Wilkinson, Richard D. A., et al.
Publicado: (2019) -
Cathepsin V regulates cell cycle progression and histone stability in the nucleus of breast cancer cells
por: Sereesongsaeng, Naphannop, et al.
Publicado: (2023) -
Cathepsin V suppresses GATA3 protein expression in luminal A breast cancer
por: Sereesongsaeng, Naphannop, et al.
Publicado: (2020) -
Antibody Targeting of Cathepsin S Inhibits Angiogenesis and Synergistically Enhances Anti-VEGF
por: Ward, Claire, et al.
Publicado: (2010)